Edition:
United States

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

4.87USD
12:19pm EST
Change (% chg)

$-0.12 (-2.40%)
Prev Close
$4.99
Open
$5.05
Day's High
$5.11
Day's Low
$4.75
Volume
211,400
Avg. Vol
170,172
52-wk High
$16.65
52-wk Low
$1.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.55 -0.556
Jun '17 1.15 -0.677
Mar '17 1.02 -0.603
FY 2016 Dec '16 4.06 -0.376
Sep '16 1.72 -0.537
Jun '16 1.45 -0.473
Mar '16 1.16 -0.870
FY 2015 Dec '15 1.23 -0.415
Sep '15 1.20 -0.488
Jun '15 1.07 0.004
Mar '15 0.81 -0.319
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 1.42 1.60 1.10 2.00
Quarter Ending Mar-18 1 1.03 1.03 1.03 0.00
Year Ending Dec-17 3 5.14 5.32 4.82 2.53
Year Ending Dec-18 3 2.46 5.37 0.00 4.75
Earnings (per share)
Quarter Ending Dec-17 3 -0.68 -0.61 -0.72 -0.62
Quarter Ending Mar-18 2 -0.60 -0.49 -0.70 -0.61
Year Ending Dec-17 3 -2.56 -2.44 -2.69 -2.40
Year Ending Dec-18 4 -2.51 -1.89 -2.99 -2.74
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 16.18 122.78 5.95
Price to Book (MRQ) 3.27 23.45 5.68
Price to Tangible Book (MRQ) 3.28 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 68.84 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -9.56 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 39.96 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -3.64 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 3.58 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 4.21 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -717.57 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -720.72 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -712.50 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -712.50 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 109,563 22,314,532 851,801,741
Net Income/Employee (TTM) -780,634 -1,997,855 99,542,701
Receivable Turnover (TTM) 10.21 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.09 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.38 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -78.29 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -86.40 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 94.43 94.41 --
EPS (TTM) % -68.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteostasis Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.84%
# of Holders: 53
Total Shares Held: 17,358,980
3 Mo. Net Change: -1,310,417
# New Positions: 5
# Closed Positions: 19
# Increased Positions: 20
# Reduced Positions: 29
# Net Buyers: -9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.